» Articles » PMID: 24031753

Detection of Extended Spectrum Beta Lactamases, Ampc Beta Lactamases and Metallobetalactamases in Clinical Isolates of Ceftazidime Resistant Pseudomonas Aeruginosa

Overview
Specialty Microbiology
Date 2013 Sep 14
PMID 24031753
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the prevalence of ceftazidime resistance in Pseudomonas aeruginosa and the rates of extended-spectrum β-lactamase (ESBL), AmpC β-lactamase (AmpC) and metallo-β-lactamase (MBL) production among the ceftazidime resistant Pseudomonas aeruginosa. A very high rate of MBL production was observed, which suggested it to be an important contributing factor for ceftazidime resistance among Pseudomonas aeruginosa.

Citing Articles

Phenotypic and molecular characterization of extended spectrum- and metallo- beta lactamase producing Pseudomonas aeruginosa clinical isolates from Egypt.

Edward E, El Shehawy M, Abouelfetouh A, Aboulmagd E Infection. 2024; 52(6):2399-2414.

PMID: 38824475 PMC: 11621155. DOI: 10.1007/s15010-024-02297-8.


Clinical characteristics and antibiotic treatment of peritoneal dialysis-associated peritonitis caused by species: a review of 15 years' experience from southern China.

Dong X, Xie C, Yi C, Ye P, Ye H, Guo Q Microbiol Spectr. 2024; 12(6):e0009624.

PMID: 38695572 PMC: 11237785. DOI: 10.1128/spectrum.00096-24.


Genomic and Metabolic Characteristics of the Pathogenicity in .

de Sousa T, Hebraud M, Dapkevicius M, Maltez L, Pereira J, Capita R Int J Mol Sci. 2021; 22(23).

PMID: 34884697 PMC: 8657582. DOI: 10.3390/ijms222312892.


Distribution of , , and genes among ESBL-producing isolated from Qazvin and Tehran hospitals, Iran.

Peymani A, Naserpour-Farivar T, Zare E, Azarhoosh K J Prev Med Hyg. 2017; 58(2):E155-E160.

PMID: 28900355 PMC: 5584084.


Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.

Moradali M, Ghods S, Rehm B Front Cell Infect Microbiol. 2017; 7:39.

PMID: 28261568 PMC: 5310132. DOI: 10.3389/fcimb.2017.00039.


References
1.
Walsh T, Toleman M, Poirel L, Nordmann P . Metallo-beta-lactamases: the quiet before the storm?. Clin Microbiol Rev. 2005; 18(2):306-25. PMC: 1082798. DOI: 10.1128/CMR.18.2.306-325.2005. View

2.
Jiang X, Zhang Z, Li M, Zhou D, Ruan F, Lu Y . Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006; 50(9):2990-5. PMC: 1563526. DOI: 10.1128/AAC.01511-05. View

3.
Noyal M, Menezes G, Harish B, Sujatha S, Parija S . Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res. 2009; 129(6):707-12. View

4.
Dong F, Xu X, Song W, Lu P, Yu S, Yang Y . Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China. Chin Med J (Engl). 2008; 121(17):1611-6. View

5.
Bradford P . Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4):933-51, table of contents. PMC: 89009. DOI: 10.1128/CMR.14.4.933-951.2001. View